‘N-Free’ Labels on Nail Polishes doesn’t verify that they are free Of Toxic Compounds

Nail polish, a very common product used by most of the women in India. But everyone is not aware of the potential health effects of nail polish. Though various manufacturers fooling their customers with labeling their products “N-Free” which signifies they are free from toxic ingredients but it’s not true. According to the report published in the Environmental Science & Technology, these labels aren’t always accurate, and reformulated products aren’t necessarily safer.

In the year, 2000 the concerns arose regarding the use of Plasticizers di-n-butyl phthalate (DnBP) which improves the flexibility and chip resistance in the nail polishes but its a reproductive and developmental toxicant. Then manufacturers replaced its usage with the other plasticizers. New nail polishes came to the market with the new labeled like “3-Free,” which means the products are free from the “toxic trio” of DnBP, toluene, and formaldehyde.

Manufacturers start following the trend and now products are labeled N-Free to signifies the product is safe and free from 13 different chemicals. However, there’s little standardization about which chemicals are excluded but recently some reports proved that some substitutes like the plasticizer triphenyl phosphate (TPHP) is also harmful. This case raised the concern that one toxic replaced with another toxic and this is called “regrettable substitution.”

Anna Young and colleagues studied DnBP substitutes in the nail polish and then analyzed the types and accuracy of plasticizer labeling. This study helps in giving producers, consumers and nail salons guidance in designing and selecting safer nail polish materials.

40 different nail polishes get examined by the scientists and found manufacturers have generally removed DnBP and are reducing the amount of TPHP they use. But some producers are using toxic substitutes, like bis(2-ethylhexyl) phthalate, sometimes without disclosing the compounds.

Labeling is not always accurate. Anna Young said that with this simple standardization or validation of the claims, it’s challenging for consumers and nail salon workers to know what these labels really mean for health. Anna young also added that it’s not as simple as what substances aren’t in nail polish; we have to address harmful chemicals still present or added as substitutes.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation

    4 arrested in Nashik for illegally procuring prescription drugs online & selling to gym-goers

    4 arrested in Nashik for illegally procuring prescription drugs online & selling to gym-goers

    CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

    CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

    Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

    Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

    Assam: Drug inspector couple dismissed from service over bribery, disproportionate assets cases

    Assam: Drug inspector couple dismissed from service over bribery, disproportionate assets cases